LRRK2 phosphorylation of Rab GTPases in Parkinson’s disease

By Suzanne Pfeffer, PhD
View Published Article

Output Details

Description

This review highlights new findings related to LRRK2-mediated phosphorylation of Rab GTPases and its consequences.

Identifier (DOI)
10.1002/1873-3468.14492
Tags
  • LRRK2
  • Rab GTPases
  • Review
Team
Team Alessi
Program
Collaborative Research Network
Theme
PD Functional Genomics

Meet the Authors

Related Research

PINK1 WT/LRRK2 WT, PINK1 WT/LRRK2 RC, PINK1 KO/LRRK2 WT, PINK1 KO/LRRK2 RC

Mice with LRRK2 R1441C and PINK1 KO mutations were crossed to create double mutant lines: LRRK2 WT/PINK1 WT, LRRK2 RC/PINK1 WT, LRRK2 WT/PINK1 KO, and LRRK2 RC/PINK1 KO.

View Lab Material

LRRK2 R1441C/PINK1 Double mutant mouse embryonic fibroblasts

LRRK2 R1441C/PINK1 double mutant mouse embryonic fibroblasts were studied alongside homozygous mutant and littermatched wild-type cells.

View Lab Material

Leucine Rich Repeat Kinase 2: Pathways to Parkinson’s Disease

Research on LRRK2 in Parkinson's disease has advanced, revealing how mutations activate the kinase, phosphorylate Rab proteins, disrupt cell functions like Hedgehog signaling, and contribute to the disease. LRRK2 inhibitors show promise for therapy.

View Article
View More Outputs
Aligning Science Across Parkinson's
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.